Efficacy of Early Tracheostomy to Reduce Incidence of Ventilator Acquired Pneumonia (VAP)
1 other identifier
interventional
320
1 country
1
Brief Summary
The study aims to assess early (one to three days after intubation) tracheostomy effectiveness in terms of reduction in ventilator associated pneumonia (VAP) incidence.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_3
Started Jun 2004
Typical duration for phase_3
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2004
CompletedFirst Submitted
Initial submission to the registry
December 5, 2005
CompletedFirst Posted
Study publicly available on registry
December 6, 2005
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2008
CompletedJune 8, 2012
June 1, 2012
4 years
December 5, 2005
June 7, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Increase of "ventilator associated pneumonia-free days"
Follow-up terminates on day 28 from the date of oro/nasotracheal intubation.
Secondary Outcomes (2)
Increase of "ventilator-free days"
Follow-up terminates on day 28 from the date of oro/nasotracheal intubation
Reduction of mortality
one year
Study Arms (2)
Early (A)
ACTIVE COMPARATORPatients of the EARLY group (A) will be submitted to tracheostomy on day 3-5 from oro/nasotracheal intubation.
Late (B)
ACTIVE COMPARATORPatients of the LATE group (B) will undergo tracheostomy on day 10-12 from oro/nasotracheal intubation.
Interventions
Upon admission to ICU, acute respiratory failure patients requiring at least 3 days of mechanical ventilation and defined by a SAPS II score between 35 and 65, will be randomly assigned to either arm A or B of the study.
Eligibility Criteria
You may qualify if:
- Oro/nasotracheal intubation for less than three days
- Simplified Acute Physiology Score (SAPS II) between 35 and 65 upon admission to Intensive Care Unit (ICU)
You may not qualify if:
- Oro/nasotracheal intubation \> three days
- Age \< 18 years
- Previous otolaryngologic or maxillofacial procedures
- Brain injury patients with intracranial pressure \> 20 mmHg without pharmacological treatment (or intracranial pressure \> 15 mmHg under specific pharmacological treatment) and with cerebral perfusion pressure \< 60 mmHg
- Pregnancy
- Ventilator associated pneumonia, hospital acquired pneumonia, community acquired pneumonia diagnosis before randomization
- Infection in the tracheostomic area
- Acute worsening of chronic obstructive pulmonary disease (COPD)
- Pre-existing malignancies in the tracheostomic area
- Immunosuppressed and/or immunodepressed patients:
- leukocytes \< 1000/microliters
- neutrophils \< 500/microliters
- AIDS
- long-term steroid treatment (daily dose \> 0.5 mg/kg for more than 30 days)
- Patients already enrolled in other trials
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Turin, Italylead
- Regione Piemontecollaborator
Study Sites (1)
University of Turin, Department of Anesthesia and Intensive Care Medicine
Turin, 10126, Italy
Related Publications (1)
Terragni PP, Antonelli M, Fumagalli R, Faggiano C, Berardino M, Pallavicini FB, Miletto A, Mangione S, Sinardi AU, Pastorelli M, Vivaldi N, Pasetto A, Della Rocca G, Urbino R, Filippini C, Pagano E, Evangelista A, Ciccone G, Mascia L, Ranieri VM. Early vs late tracheotomy for prevention of pneumonia in mechanically ventilated adult ICU patients: a randomized controlled trial. JAMA. 2010 Apr 21;303(15):1483-9. doi: 10.1001/jama.2010.447.
PMID: 20407057DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
V. M. Ranieri, MD
University of Turin, Italy
- STUDY DIRECTOR
V. M. Ranieri, MD
University of Turin, Italy
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
December 5, 2005
First Posted
December 6, 2005
Study Start
June 1, 2004
Primary Completion
June 1, 2008
Study Completion
October 1, 2008
Last Updated
June 8, 2012
Record last verified: 2012-06